TEE
LOGC

Tibra Equities Europe’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

Tibra Equities Europe’s Portfolio LOGC Stock Details LOGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-76,500
Closed -$340K – 241
2021
Q2 		$340K Buy
+76,500
New +$340K 0.11% 85